The aim of this review was to describe the novel treatments for PD that are currently under investigation and study and the possible therapeutic targets.

31 июл. 2020 г. · Treatment options for PD are limited, with most of the current approaches based on restoration of dopaminergic tone in the striatum.

20 янв. 2024 г. · We present the latest evidence supporting the optimal treatment of Parkinson's disease, and describe an expert approach to many aspects of treatment choice.

In 2019, the FDA approved istradefylline (Nourianz), an adenosine A2 receptor antagonist, as adjunctive treatment for levodopa/carbidopa in patients with PD ...

27 сент. 2024 г. · Levodopa is the most effective Parkinson's disease medicine. It is a natural chemical that passes into the brain and becomes dopamine. Levodopa ...

In this review, we discuss the most advanced therapeutic strategies that can be used to treat PD. We also critically review the shift of the therapeutic ...

11 февр. 2020 г. · Treatment is symptomatic, focused on improvement in motor (eg, tremor, rigidity, bradykinesia) and nonmotor (eg, constipation, cognition, mood, sleep) signs ...

The most effective symptomatic treatment remains levodopa, which has superior benefits for quality of life in early PD compared to other therapies. Motor ...

It summarizes the key points of the five novel therapies of PD included in this review—gene therapy, cell-based therapies, targeted drug delivery, ...

This review discusses both the established and new possibilities for PD treatment that can provide patient-specific care and mitigate side effects for common ...